Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Children's Oncology Group
University of Florida
Essen Biotech
Perspective Therapeutics
Ocellaris Pharma, Inc.
Tanabe Pharma America, Inc.
Hadassah Medical Organization
Incyte Corporation
Cyteir Therapeutics, Inc.
NantCell, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Innolake Biopharm
Kineta Inc.
NKGen Biotech, Inc.
Shenzhen BinDeBio Ltd.
Celldex Therapeutics
Duke University
University of Kentucky
AGO Study Group
Fred Hutchinson Cancer Center